CAMPHOR (SYNTHETIC) AND MENTHOL, UNSPECIFIED FORM

CAMPHOR (SYNTHETIC) AND MENTHOL, UNSPECIFIED FORM was reported 84 times

CAMPHOR (SYNTHETIC) AND MENTHOL, UNSPECIFIED FORM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEMICAL BURN OF RESPIRATORY TRACT 1 0.0128
1 SERUM AMYLOID A PROTEIN INCREASED 1 0.0065
2 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 1 0.0051
3 EPIDURAL INJECTION 1 0.0051
4 EXPOSURE VIA INHALATION 1 0.0046
5 CATHETER SITE RELATED REACTION 1 0.0013
6 PERIORBITAL PAIN 1 0.0012
7 MEDICATION OVERUSE HEADACHE 1 0.0012
8 BURNS SECOND DEGREE 2 0.0011
9 BURNS THIRD DEGREE 1 0.0009
10 CARDIAC HYPERTROPHY 1 0.0009
11 CATHETER SITE DISCHARGE 1 0.0009
12 OVARIAN CYST RUPTURED 1 0.0008
13 TONGUE DRY 1 0.0007
14 HALLUCINATIONS, MIXED 3 0.0007
15 CONNECTIVE TISSUE DISORDER 1 0.0007
16 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
17 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
18 DEAFNESS BILATERAL 1 0.0006
19 ESSENTIAL HYPERTENSION 1 0.0005
20 NIPPLE PAIN 1 0.0005
21 MENOPAUSE 1 0.0004
22 ANORGASMIA 1 0.0004
23 JOINT LOCK 1 0.0004
24 HEART VALVE INCOMPETENCE 1 0.0003
25 VITAMIN B12 DECREASED 1 0.0003
26 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
27 SINUS HEADACHE 2 0.0003
28 ATYPICAL PNEUMONIA 1 0.0003
29 SKIN MASS 2 0.0003
30 PLANTAR FASCIITIS 1 0.0003
31 PARANASAL SINUS DISCOMFORT 1 0.0003
32 BOWEL MOVEMENT IRREGULARITY 2 0.0003
33 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
34 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
35 OESOPHAGEAL CANDIDIASIS 1 0.0003
36 ENURESIS 1 0.0002
37 SLEEP TERROR 1 0.0002
38 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
39 HEPATIC PAIN 1 0.0002
40 LIGAMENT RUPTURE 1 0.0002
41 HAEMOGLOBIN INCREASED 1 0.0002
42 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
43 SKIN TIGHTNESS 1 0.0002
44 VULVOVAGINAL PAIN 1 0.0002
45 INCREASED UPPER AIRWAY SECRETION 1 0.0002
46 SENSITIVITY TO WEATHER CHANGE 1 0.0002
47 PHARYNGOLARYNGEAL PAIN 1 0.0002
48 PRE-EXISTING CONDITION IMPROVED 1 0.0002
49 PROCTALGIA 1 0.0002
50 HERPES SIMPLEX 1 0.0002
51 TENDON DISORDER 1 0.0002
52 MENINGITIS 1 0.0001
53 ONYCHOCLASIS 1 0.0001
54 APPLICATION SITE REACTION 1 0.0001
55 SEASONAL ALLERGY 2 0.0001
56 CEREBRAL DISORDER 1 0.0001
57 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
58 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
59 CONCUSSION 1 0.0001
60 MULTIPLE ALLERGIES 1 0.0001
61 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
62 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
63 FRUSTRATION TOLERANCE DECREASED 1 0.0001
64 ESCHERICHIA INFECTION 1 0.0001
65 INADEQUATE ANALGESIA 1 0.0001
66 BLOOD CALCIUM INCREASED 1 0.0001
67 INCREASED TENDENCY TO BRUISE 1 0.0001
68 OVARIAN CANCER 1 0.0001
69 FLANK PAIN 1 0.0001
70 SPUTUM DISCOLOURED 1 0.0001
71 THERAPY CHANGE 1 0.0001
72 DISORIENTATION 4 0.0001
73 OVARIAN CYST 1 0.0001
74 EUPHORIC MOOD 1 0.0001
75 TEMPERATURE INTOLERANCE 1 0.0001
76 VENTRICULAR EXTRASYSTOLES 1 0.0001
77 PRODUCT ODOUR ABNORMAL 1 0.0001
78 BODY HEIGHT DECREASED 1 0.0001
79 IRRITABLE BOWEL SYNDROME 2 0.0001
80 DECREASED ACTIVITY 1 0.0001
81 ORAL PAIN 2 0.0001
82 APPLICATION SITE PRURITUS 2 0.0001
83 MICTURITION URGENCY 1 0.0001
84 SPLENOMEGALY 1 0.0001
85 SPINAL PAIN 1 0.0001
86 BURSITIS 1 0.0001
87 INCORRECT PRODUCT STORAGE 1 0.0001
88 PRODUCT TASTE ABNORMAL 1 0.0001
89 APPLICATION SITE RASH 1 0.0001
90 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
91 CARPAL TUNNEL SYNDROME 1 0.0001
92 BLINDNESS UNILATERAL 1 0.0001
93 PAIN IN JAW 2 0.0001
94 MUSCULOSKELETAL CHEST PAIN 1 0.0001
95 TENDONITIS 1 0.0001
96 MUSCLE TIGHTNESS 1 0.0001
97 BLOOD POTASSIUM INCREASED 1 0.0001
98 URINARY RETENTION 2 0.0001
99 CANDIDA INFECTION 1 0.0001
100 MUSCULOSKELETAL DISCOMFORT 1 0.0001
101 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
102 THIRST 1 0.0001
103 TOOTHACHE 1 0.0001
104 HEPATIC STEATOSIS 1 0.0001
105 BLISTER 3 0.0001
106 DYSPNOEA EXERTIONAL 2 0.0001
107 CHOLESTASIS 1 0.0001
108 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
109 SINUS DISORDER 1 0.0001
110 FULL BLOOD COUNT DECREASED 1 0.0000
111 PRODUCT PHYSICAL ISSUE 1 0.0000
112 RIB FRACTURE 1 0.0000
113 PULMONARY HYPERTENSION 1 0.0000
114 FAECES DISCOLOURED 1 0.0000
115 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
116 APPLICATION SITE PAIN 1 0.0000
117 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
118 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
119 SKIN IRRITATION 2 0.0000
120 MENTAL IMPAIRMENT 1 0.0000
121 NEURALGIA 1 0.0000
122 AGEUSIA 1 0.0000
123 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
124 ANAPHYLACTIC SHOCK 1 0.0000
125 BACK PAIN 9 0.0000
126 APPLICATION SITE ERYTHEMA 1 0.0000
127 FREQUENT BOWEL MOVEMENTS 1 0.0000
128 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
129 INTENTIONAL DOSE OMISSION 1 0.0000
130 PSYCHOTIC DISORDER 1 0.0000
131 IRRITABILITY 2 0.0000
132 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
133 DISCOMFORT 2 0.0000
134 PERIPHERAL SWELLING 5 0.0000
135 NEUROPATHY PERIPHERAL 3 0.0000
136 CYSTITIS 1 0.0000
137 CHOLELITHIASIS 1 0.0000
138 TREMOR 5 0.0000
139 ANGER 1 0.0000
140 HAEMATURIA 1 0.0000
141 GASTRIC DISORDER 1 0.0000
142 RASH MACULAR 1 0.0000
143 BURNING SENSATION 2 0.0000
144 LYMPHADENOPATHY 1 0.0000
145 MOBILITY DECREASED 2 0.0000
146 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
147 CRYING 1 0.0000
148 C-REACTIVE PROTEIN INCREASED 1 0.0000
149 BRONCHITIS 2 0.0000
150 RHEUMATOID ARTHRITIS 3 0.0000
151 ARTHRITIS 2 0.0000
152 POLLAKIURIA 1 0.0000
153 ROAD TRAFFIC ACCIDENT 1 0.0000
154 URTICARIA 4 0.0000
155 OSTEOARTHRITIS 1 0.0000
156 HYPOACUSIS 1 0.0000
157 PSORIASIS 3 0.0000
158 MUSCULOSKELETAL STIFFNESS 2 0.0000
159 RENAL FAILURE 3 0.0000
160 THERAPY NON-RESPONDER 1 0.0000
161 NEPHROLITHIASIS 1 0.0000
162 SKIN DISCOLOURATION 1 0.0000
163 COGNITIVE DISORDER 1 0.0000
164 DYSPHAGIA 2 0.0000
165 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
166 CONTUSION 2 0.0000
167 LUNG DISORDER 1 0.0000
168 FLUSHING 2 0.0000
169 CHEST DISCOMFORT 2 0.0000
170 SINUSITIS 2 0.0000
171 THERAPY CESSATION 1 0.0000
172 SPEECH DISORDER 1 0.0000
173 DEPRESSED MOOD 1 0.0000
174 DRUG EFFECT DECREASED 1 0.0000
175 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
176 ARTHROPATHY 1 0.0000
177 NECK PAIN 1 0.0000
178 PANCYTOPENIA 1 0.0000
179 OXYGEN SATURATION DECREASED 1 0.0000
180 FLATULENCE 1 0.0000
181 SEIZURE 2 0.0000
182 BONE PAIN 1 0.0000
183 NASAL CONGESTION 1 0.0000
184 DISEASE PROGRESSION 2 0.0000
185 CATARACT 1 0.0000
186 JOINT SWELLING 2 0.0000
187 STOMATITIS 1 0.0000
188 VISUAL IMPAIRMENT 2 0.0000
189 HYPERHIDROSIS 2 0.0000
190 AMNESIA 1 0.0000
191 PRODUCT DOSE OMISSION 1 0.0000
192 PAIN 9 0.0000
193 ERYTHEMA 3 0.0000
194 MEMORY IMPAIRMENT 2 0.0000
195 INJURY 1 0.0000
196 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
197 PRODUCT DOSE OMISSION ISSUE 4 0.0000
198 PAIN IN EXTREMITY 4 0.0000
199 WEIGHT INCREASED 3 0.0000
200 UNEVALUABLE EVENT 1 0.0000
201 CARDIAC FAILURE CONGESTIVE 1 0.0000
202 DRY MOUTH 1 0.0000
203 NAUSEA 9 0.0000
204 TACHYCARDIA 1 0.0000
205 GASTROINTESTINAL DISORDER 1 0.0000
206 ADVERSE EVENT 1 0.0000
207 ASTHENIA 4 0.0000
208 MIGRAINE 1 0.0000
209 PRURITUS 4 0.0000
210 DRUG INTOLERANCE 1 0.0000
211 ATRIAL FIBRILLATION 1 0.0000
212 DYSPEPSIA 1 0.0000
213 SYNCOPE 1 0.0000
214 HYPOTENSION 2 0.0000
215 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
216 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
217 ARTHRALGIA 4 0.0000
218 FALL 3 0.0000
219 ASTHMA 1 0.0000
220 DYSPNOEA 5 0.0000
221 DEPRESSION 2 0.0000
222 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
223 ABDOMINAL PAIN 2 0.0000
224 CHILLS 1 0.0000
225 VOMITING 4 0.0000
226 OEDEMA PERIPHERAL 1 0.0000
227 FATIGUE 6 0.0000
228 DRUG INEFFECTIVE 10 0.0000
229 WEIGHT DECREASED 2 0.0000
230 COUGH 2 0.0000
231 ANXIETY 2 0.0000
232 RASH 3 0.0000
233 HYPOAESTHESIA 1 0.0000
234 BLOOD PRESSURE INCREASED 1 0.0000
235 PNEUMONIA 2 0.0000
236 DRUG DOSE OMISSION 1 0.0000
237 DIZZINESS 3 0.0000
238 ABDOMINAL DISCOMFORT 1 0.0000
239 MYALGIA 1 0.0000
240 URINARY TRACT INFECTION 1 0.0000
241 PYREXIA 2 0.0000
242 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
243 MUSCLE SPASMS 1 0.0000
244 NASOPHARYNGITIS 1 0.0000
245 CHEST PAIN 1 0.0000
246 HYPERSENSITIVITY 1 0.0000
247 PRODUCT USE ISSUE 1 0.0000
248 BLOOD GLUCOSE INCREASED 1 0.0000
249 GAIT DISTURBANCE 1 0.0000
250 ABDOMINAL PAIN UPPER 1 0.0000
251 HEADACHE 3 0.0000
252 DIARRHOEA 3 0.0000
253 CONSTIPATION 1 0.0000
254 INCORRECT DOSE ADMINISTERED 1 0.0000
255 DECREASED APPETITE 1 0.0000
256 FEELING ABNORMAL 1 0.0000
257 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
258 INSOMNIA 1 0.0000
259 CONDITION AGGRAVATED 1 0.0000
260 INJECTION SITE PAIN 1 0.0000
261 MALAISE 1 0.0000